Introduction
============

Chronic obstructive pulmonary disease (COPD) is and will continue to be a major public health problem in both developed and developing countries ([@b62-copd-2-253], [@b63-copd-2-253]; [@b87-copd-2-253]). Progressive introduction of pharmacologic, nonpharmacologic and surgical treatments are often necessary to cope with the deteriorating respiratory function in COPD ([@b68-copd-2-253]). Treatment effectiveness in any condition depends not only on the appropriateness of the drugs prescribed and/or the recommendations given, but also on patient commitment to the intended treatment ([@b58-copd-2-253]). Failure to take medicines as intended or deviations from recommended management might result in therapeutic failure as well as wastage of health resources ([@b59-copd-2-253]; [@b15-copd-2-253]; [@b77-copd-2-253]; [@b47-copd-2-253]). Health professionals may be unaware of their patients' drug utilization patterns and may underestimate the effectiveness of drug regimens, in turn leading to prescribing errors ([@b60-copd-2-253]). The importance of patient commitment for the success of COPD management programs is well recognised ([@b68-copd-2-253]).

The extent to which a person's behavior (in terms of taking medications, following diets, or executing lifestyle changes) coincides with medical or health advice was labeled as 'compliance' in late 1970s ([@b42-copd-2-253]). In the modern era patient rights not to follow the medical advice is well recognized and 'compliance' is regarded to be politically incorrect. It is increasingly being replaced with 'adherence', which is less judgmental and more respectful of the role that patients can play in their own treatment ([@b58-copd-2-253]). Deviations from clinical prescriptions or recommendations have been evaluated quantitatively and qualitatively. Quantitative definitions for medication adherence often refer to the extent of those deviations and include amount of medicine taken over a given time period, or to the extent of its correlation with aspects such as the recommended timing of the medication, the intended duration of the treatment and the recommended method of administration ([@b58-copd-2-253]). Based on the extent of utilization, three patterns of medication nonadherence -- viz 'underutilization', 'over utilization' and 'inappropriate use' have been reported ([@b22-copd-2-253]). In a meta-analysis of studies reporting adherence to medical treatment, the average nonadherence rate was found to be 24.8% ([@b20-copd-2-253]).

Qualitative definitions refer to variables such as intentionality, memory and health beliefs that result in deviations from the recommended treatment ([@b58-copd-2-253]). Deviations from treatment recommendations could be intentional and/or unintentional. 'Unintentional nonadherence' may be due to simple forgetfulness, or inability to follow treatment instructions because of poor understanding or physical problems such as poor eyesight or dexterity problems ([@b58-copd-2-253]). 'Intentional nonadherence' arises when the patient rejects either the doctor's diagnosis or the doctor's recommended treatment ([@b45-copd-2-253]; [@b58-copd-2-253]). The latter is often a rational decision made by the patient to reject either the diagnosis or the recommended treatment after careful consideration of the perceived risks/costs versus benefits and has been called 'intelligent nonadherence' ([@b86-copd-2-253]). It is often driven by patient beliefs and experiences about illness and treatment, which are in turn influenced by social and cultural factors. This paper gives an overview of adherence research in COPD with a focus on the methods employed for studying adherence and the factors associated with adherent behavior.

A literature search using OVID and International Pharmaceutical Abstracts (IPA) was performed with the following terms: (COPD OR bronchitis OR emphysema) AND (adherence OR compliance OR concordance). Relevant articles were selected after reviewing the abstracts.

Adherence in COPD
=================

Adherence to both pharmacological and non-pharmacological management is critical for optimal outcomes in patients with COPD ([@b68-copd-2-253]). Good medication adherence was associated with both decrease in the number of hospitalizations and length of hospital stay among patients with chronic respiratory ailments ([@b5-copd-2-253]). It would be reasonable to assume that in a symptomatic disease with progressive decline in quality of life such as COPD, patients would strictly follow the medical advice. However, in a meta analysis of adherence studies, the mean adherence to medical treatment in pulmonary diseases was found to be only 68.8% ([@b21-copd-2-253]), which was much less compared to mean adherence in other chronic disease conditions. Nonadherence in COPD is a multi-dimensional quandary and includes short and long-term medication nonadherence ([@b13-copd-2-253]; [@b79-copd-2-253]; [@b52-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b71-copd-2-253], [@b70-copd-2-253]; [@b81-copd-2-253]; [@b8-copd-2-253]; [@b41-copd-2-253]; [@b69-copd-2-253]; [@b74-copd-2-253], [@b75-copd-2-253]; [@b18-copd-2-253]; [@b30-copd-2-253]; [@b5-copd-2-253]; [@b85-copd-2-253]), nonadherence to life style changes such as smoking cessation ([@b52-copd-2-253]; [@b70-copd-2-253]; [@b81-copd-2-253]; [@b30-copd-2-253]; [@b88-copd-2-253]; [@b57-copd-2-253]; [@b75-copd-2-253]), non-participation in or early withdrawal from respiratory rehabilitation or exercise programs ([@b88-copd-2-253]; [@b25-copd-2-253]; [@b4-copd-2-253]), failure to meet vaccination requirements ([@b27-copd-2-253]; [@b65-copd-2-253]; [@b31-copd-2-253]), missing scheduled clinic or home visits ([@b81-copd-2-253]; [@b41-copd-2-253]), and inadequate monitoring of treatment response ([@b30-copd-2-253]). Underutilization ([@b79-copd-2-253]; [@b52-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b41-copd-2-253]), overutilization ([@b13-copd-2-253]; [@b52-copd-2-253]; [@b22-copd-2-253]; [@b69-copd-2-253]) and inappropriate use ([@b1-copd-2-253]; [@b46-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b11-copd-2-253]; [@b67-copd-2-253]; [@b38-copd-2-253], [@b39-copd-2-253]; [@b80-copd-2-253]; [@b82-copd-2-253]; [@b53-copd-2-253]; [@b85-copd-2-253]) of medications have been reported among patients with COPD. Poor adherence to drug therapy and disease management programs has been identified as the major factor resulting in emergency hospitalization among COPD patients ([@b15-copd-2-253]; [@b29-copd-2-253]; [@b31-copd-2-253]).

Adherence evaluation in COPD
============================

Various direct and indirect methods have been used for evaluating treatment adherence in COPD. The majority of the adherence studies have been carried out from the health professionals' perspective with little regard for the perspective of patients. Wide variation exists in the definitions, classifications and 'cut-off values' for optimal adherence in different studies. Each method has its own limitations and advantages. Wide variations were observed in the extent of nonadherence reported among COPD patients, based on the definition of adherence used, the method of assessment, the focus characteristic chosen for adherence assessment, 'cut-off values' for classification as adherent or nonadherent, patient population, time of assessment, and duration of follow-up. An overview of the various methods used for assessing adherence in COPD is given in Table [1](#t1-copd-2-253){ref-type="table"}.

Few researchers have used multiple methods or tools to study adherence in their study population and compared the results ([@b79-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b71-copd-2-253], [@b70-copd-2-253]; [@b66-copd-2-253]; [@b9-copd-2-253]; [@b75-copd-2-253]). Self-reporting of missed doses underestimated nonadherence when compared to more objective measures such as capsule count ([@b23-copd-2-253]), inhaler weights ([@b70-copd-2-253]) and electronic monitoring ([@b71-copd-2-253]; [@b10-copd-2-253]; [@b75-copd-2-253]). Self-report had moderate reliability (25%--67%) when compared against more objectives measures of adherence such as canister weight ([@b70-copd-2-253]) and electronic monitoring ([@b37-copd-2-253]; [@b66-copd-2-253]; [@b9-copd-2-253]). Being aware of monitoring of medication adherence using objective methods such as electronic monitoring might encourage some patients to exaggerate their self-reported adherence ([@b76-copd-2-253]). Awareness of monitoring device or feedback on monitoring results might improve patient adherence with the medication(s) under surveillance ([@b66-copd-2-253]; [@b81-copd-2-253]), but at the same time patients could be nonadherent with any medications unmonitored ([@b81-copd-2-253]).

Electronic monitors provide more objective and reliable information on adherence than any other measures of adherence that are currently available. However, they are useful only to detect the presence of a problem (nonadherence); they are unable to find the cause of the problem. For example, intentional nonadherence (such as steroid phobia) cannot be differentiated from unintentional nonadherence (eg, forgetfulness). Hence electronic monitors are not helpful in finding solutions for the issue, even if detected. Moreover, the feasibility and cost effectiveness of electronic monitoring in routine clinical practice are doubtful ([@b37-copd-2-253]). In the era of 'concordance' where adherence is assumed to be the joint responsibility of the patient and health professionals, the use of such devices without patient knowledge is unethical and might even disrupt the mutual relationship between the health professionals and patients. Currently electronic monitors are not available for all the available dosage forms (eg, strip-packed tablets). Electronic monitoring cannot ensure that the medication withdrawn from the container had actually been consumed. Technical problems like battery failure or data retrieval problems have been shown to result in loss of adherence data, suggesting that researchers should not depend entirely on electronic monitors for monitoring adherence ([@b37-copd-2-253]; [@b66-copd-2-253]; [@b10-copd-2-253]; [@b74-copd-2-253], [@b73-copd-2-253], [@b75-copd-2-253]). Self-report of nonadherence has been shown to have satisfactory reliability among patients with COPD, when verified against objective measures ([@b22-copd-2-253]; [@b66-copd-2-253]; [@b70-copd-2-253]). Overestimation of adherence and poor reliability are common criticisms about self-reports; however, people who report nonadherence are likely to tell the truth ([@b43-copd-2-253]; [@b50-copd-2-253]; [@b12-copd-2-253]; [@b26-copd-2-253]).

Very few studies have incorporated inhalation technique assessment into the medication adherence evaluation process ([@b22-copd-2-253]; [@b23-copd-2-253]; [@b81-copd-2-253]). Inhalation techniques have been assessed using checklists adapted from guidelines set by different professional organizations ([@b1-copd-2-253]; [@b3-copd-2-253]; [@b46-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b11-copd-2-253]; [@b67-copd-2-253]; [@b38-copd-2-253], [@b39-copd-2-253]; [@b80-copd-2-253]; [@b83-copd-2-253], [@b84-copd-2-253]; [@b82-copd-2-253]; [@b53-copd-2-253]). Only few researchers have assessed the total inhaler technique ([@b46-copd-2-253]; [@b23-copd-2-253]; [@b17-copd-2-253]), while others categorized the steps in the inhalation process into 'key' or 'essential' and 'non-essential' steps and assessed only those 'critical steps'.([@b23-copd-2-253]; [@b83-copd-2-253], [@b84-copd-2-253]; [@b82-copd-2-253]) Multiple raters (up to five) were involved in the assessment process in some studies ([@b1-copd-2-253]; [@b11-copd-2-253]) and the poor inter- and intra-rater reliability reported among the raters ([@b1-copd-2-253]; [@b11-copd-2-253]; [@b38-copd-2-253]), even for the 'critical steps', is a concern ([@b38-copd-2-253]). Some of the newer devices incorporate a flow sensor which has the capability to track the actual dose inhaled. Even 'objective monitoring' could detect only one of the problems associated with inhalation technique, ie, inadequate respiratory volume following canister actuation ([@b11-copd-2-253]).

Factors associated with adherence in COPD
=========================================

Patients with COPD have many potential risk factors for nonadherence. COPD being a disease condition characterized by multiple comorbidities ([@b6-copd-2-253]; [@b57-copd-2-253]; [@b16-copd-2-253]; [@b49-copd-2-253]; [@b34-copd-2-253]), patients are likely to be on complex medication regimens consisting of time-contingent and prn (when required) oral and inhaled respiratory medications ([@b22-copd-2-253]; [@b51-copd-2-253]; [@b68-copd-2-253]) as well as other medications ([@b13-copd-2-253]). Over one-third of patients with COPD were found to use complementary and alternative medicines ([@b32-copd-2-253], [@b34-copd-2-253]), adding further complexity to their already complex medication regimens. Complexity of the prescribed drug regimen in COPD is known to increase with disease severity as well as the presence of comorbidities ([@b28-copd-2-253]). Patients often need to make alterations in their drug regimen depending on disease severity, opportunistic respiratory tract infections and seasonal changes. Reduction of therapy once symptom control has been achieved is not normally possible, even though none of the existing medications for COPD has shown to modify the long-term decline in lung function ([@b68-copd-2-253]; [@b19-copd-2-253]).

According to [@b7-copd-2-253], motivating factors, and positive modifying and enabling factors contribute to adherence, while their absence or opposite effects could put adherence at risk. Factors found to be associated with adherence in COPD in various research studies could be incorporated into the Becker-Maiman model to explain adherent behavior of COPD patients (Table [2](#t2-copd-2-253){ref-type="table"}). Despite differences between these studies in methods employed to detect nonadherence, cut-off values used for classifying patients as adherent or nonadherent, and the populations studied, adherence in COPD was found to be a dynamic process controlled by the presence or absence of motivating factors, and modifying and enabling factors. The validity of this model has been confirmed in both qualitative and quantitative studies ([@b34-copd-2-253], [@b33-copd-2-253], [@b35-copd-2-253]).

Patients analyze the benefits in following a recommended treatment against the risks/cost associated with it. They are likely to disregard those treatments which in their experience have little efficacy or if there are concerns about their safety or their impact on patients' lives. Regimen complexity does not pose challenges to adherence in those who could 'routinize' their medication regimen, ie, those who could incorporate medication taking into their unique and complex daily lives ([@b72-copd-2-253]; [@b33-copd-2-253]). The need for managing a complex medication regimen could be an issue in patients with cognitive impairment and those with depressive illness, which might explain the unintentional deviations from the treatment recommendations observed in some elderly COPD patients. The poor inhalation techniques among patients is not surprising when health professionals such as doctors, respiratory therapists, nurses and pharmacists who are involved in educating patients on inhalation techniques, themselves are known to have poor knowledge and ability (mainly on the 'critical steps') to use those devices ([@b40-copd-2-253]; [@b55-copd-2-253]).

Message for health professionals and researchers
================================================

Many patients with COPD do not follow their treatment recommendations either intentionally or unintentionally. Motivating, enabling and modifying factors related to patient, disease, treatment, and health care providers could influence adherence. As time evolves COPD patients become more health conscious due to the progression of the disease and increase in disease burden, resulting in improved adherence. However, in the short-term adherence is likely to decline over time, unless enhanced by feedback and reinforcement. Patient knowledge about the role of treatment, confidence and feedback from health professionals are likely to enhance treatment adherence among COPD patients.

Adherence screening on all aspects of management should be routinely performed in patients with COPD using simple and practical tools. This need exists for all patients with COPD including those whose nonadherence has not been a concern in the past. Health professionals should devote more time for patients whose nonadherence is of concern. Identifying the nature of nonadherence and the reasons for nonadherence are also critical in clinical practice along with its detection and quantification. Multiple methods -- including objective measures -- should be employed for monitoring adherence in clinical practice, especially when nonadherence is suspected. Electronic monitoring, though regarded as the 'gold standard' for adherence monitoring, is more appropriate in a clinical trial setting where the investigators have to ensure that patients use their drugs as prescribed and need to identify those patients who are not. Self-reporting offers a cheap, simple and easy method for assessing adherent behaviors. In addition, reasons for nonadherence can be identified using self-report, which in turn would help in addressing those issues. Inhaler technique assessment forms a key component of adherence assessment in COPD and should be performed periodically.

Strategies for overcoming nonadherence have to be formulated based on the nature and reasons for nonadherence. In the event of unintentional nonadherence, especially in the elderly; those with complex medication regimens; and those with cognitive impairment, the use of adherence aids such as medication lists, Dosette boxes and timers should be promoted. Wherever possible, the recommend treatment regimens should fit into the lifestyles and limitations of patients and their families. Coordinating medication use with a daily activity; storage of medications at places closer to their use; and assistance/reminding systems for the timely administration of medicines and for regular supply of medicines might avoid unintentional nonadherence.

Understanding patient beliefs and experiences, patient education focusing on the pathology of COPD and the role of treatment, periodic monitoring and reinforcement are critical for overcoming the barriers of intentional nonadherence. The impact of patient education is likely to be enhanced if health professionals elicit patients' concerns and disappointments about their management and address those issues on an individual basis. Such efforts are likely to enhance COPD patients' confidence leading to improved patient adherence to both medications and non-pharmacological management. When the health care professionals are unsure and have questionable inhalation skills, their patients cannot be expected to use the inhalation devices properly. Training in inhalation techniques and their assessment are critical for all health professionals involved in instruction and assessment of inhalation techniques for patients. New interventions for reducing intentional and unintentional nonadherence in COPD need to be developed and tested in large randomized controlled trials.

###### 

Methods for studying adherence in patients with chronic respiratory disease

  **Method**                                                                                                                                                                                                                                                                                                     **Description**                                                                                                                                                                                                                      **Features**
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***Indirect methods***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Inhaler weights([@b13-copd-2-253]; [@b71-copd-2-253], [@b70-copd-2-253]; [@b66-copd-2-253]; [@b10-copd-2-253]; [@b75-copd-2-253])                                                                                                                                                                              Patients are asked to produce all their used inhaled medication canisters at the time of clinic or home visit, which are weighed using a balance with high sensitivity and precision.                                                Patients might fail to produce all the used canisters; does not reflect adherence distribution over time; difficult to distinguish 'test' puffs from inhaled puffs; unable to identify 'overfills' in the canister leading to wrong findings; deliberate canister emptying prior to follow-up is possible; weighing the canisters is inconvenient.
  Self-report on medication utilization ([@b52-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b71-copd-2-253], [@b70-copd-2-253]; [@b81-copd-2-253]; [@b10-copd-2-253]; [@b48-copd-2-253]; [@b31-copd-2-253]; [@b75-copd-2-253])                                                                           Patients are asked specific questions about the drug usage pattern such as doses missed, prescribed and used doses in the past or over a definite time period.                                                                       Patients might overestimate adherence to impress their health professionals; limited by patients' ability to recall the events.
  Medication adherence questionnaire ([@b61-copd-2-253]; [@b22-copd-2-253]; [@b44-copd-2-253]; [@b78-copd-2-253]; [@b34-copd-2-253], [@b35-copd-2-253])                                                                                                                                                          Specific questions on intentional and unintentional deviations from the recommended management eg, Morisky's scale ([@b61-copd-2-253]) or its modifications, and the Medication Adherence Report Scale (MARS) ([@b44-copd-2-253]).   Does not include all the factors influencing adherence; some questions could be confusing for patients on respiratory medications to be used on a 'when needed' (prn) basis; reliability needs to be tested in individual patient populations.
  Electronic monitoring eg, Datalogger, Chronolog, clock counters, MEMS (medication event monitoring system) cap ([@b76-copd-2-253]; [@b37-copd-2-253]; [@b8-copd-2-253]; [@b10-copd-2-253]; [@b69-copd-2-253]; [@b74-copd-2-253], [@b73-copd-2-253], [@b75-copd-2-253]; [@b18-copd-2-253]; [@b56-copd-2-253])   Microprocessors or data-loggers record the date and time of medication use events, such as opening the cap of a bottle or release of medication from the container.                                                                  Expensive; could be obtrusive; unethical to use without prior information to patients; could alter the natural adherence pattern in patients who are aware of the technology; confirms only medication withdrawal not administration; cannot identify multiple medication withdrawal of solid dosage forms; monitor might dysfunction; not available for adherence assessment of all dosage forms; helpful in identifying dose dumping; more suitable for use in clinical trial settings than for routine clinical purposes.
  Inhalation technique assessment ([@b1-copd-2-253]; [@b46-copd-2-253]; [@b22-copd-2-253]; [@b23-copd-2-253]; [@b11-copd-2-253]; [@b67-copd-2-253]; [@b38-copd-2-253], [@b39-copd-2-253]; [@b80-copd-2-253]; [@b82-copd-2-253]; [@b53-copd-2-253])                                                               Assessment of inhalation technique by one or more raters or objective rating using a flow sensor.                                                                                                                                    Rater assessments are subjective; depends on the expertise of rater(s); possibility of high inter- and intra-rater variability; utilization pattern in real life might be different to that during demonstration to the raters; should be combined with other measures to study medication taking behavior.
  Medication or pill count ([@b23-copd-2-253]; [@b85-copd-2-253])                                                                                                                                                                                                                                                Patients are asked to produce their medications during the clinic or home visit, which are counted.                                                                                                                                  Intrusive; tedious process especially with multiple medications; does not reflect adherence distribution over time; patients might forget to bring in used medication containers; could dump medications before clinic visit.
  Pharmacy refill data or claims data ([@b79-copd-2-253]; [@b76-copd-2-253]; [@b54-copd-2-253]; [@b30-copd-2-253]; [@b5-copd-2-253])                                                                                                                                                                             Medication refill histories or purchase data from pharmacies or claims data from the insurer.                                                                                                                                        Patients might not take their drugs despite having the prescriptions refilled; might not reflect the actual medication utilization (can hoard drugs); collection of information could be limited by privacy legislation; useful only for prescription medications; assessment is difficult in patients with multi-pharmacy patronage.
  Daily diary ([@b76-copd-2-253]; [@b37-copd-2-253]; [@b41-copd-2-253])                                                                                                                                                                                                                                          Patients record their daily medication usage or readings from monitoring devices (eg, peak-flow meter) or thera peutic response or symptoms in a diary.                                                                              Vulnerable to patient deceit; patients might forget to fill in diaries regularly.
  In-depth, structured or semi-structured interviews ([@b22-copd-2-253]; [@b24-copd-2-253]; [@b4-copd-2-253]; [@b33-copd-2-253], [@b36-copd-2-253])                                                                                                                                                              Interviews are conducted by a trained interviewer on a purposive sample based on an interview guide, which are often audio-taped, transcribed and analyzed for content and themes.                                                   Data collection and analysis is time consuming; needs skills for interviewing; use sociological theories for data analysis and interpretation; findings are not assessed based on statistical significance; investigator will have flexibility on the depth and extent of the information being gathered.
  ***Direct methods***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Biological assays ([@b79-copd-2-253]; [@b81-copd-2-253]; [@b14-copd-2-253]; [@b41-copd-2-253]; [@b75-copd-2-253])                                                                                                                                                                                              Measurement of a drug or an agent (eg, nicotine) or their metabolites or markers in biological fluids.                                                                                                                               Some techniques are invasive; assays are not available for all medications; drug interactions might alter drug levels (eg, smoking and theophylline levels).

###### 

Factors associated with medication nonadherence: Becker-Maiman model

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Factor associated with adherence**                                                                                                                                                                                                                                                                                     **Research evidence in patients with COPD**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Motivations                                                                                                                                                                                                                                                                                                              

  Concern about health matters in generalWillingness to seek and accept medical directionIntention to complyPositive health activities                                                                                                                                                                                     Perceived lack of need for medications ([@b2-copd-2-253]; [@b34-copd-2-253]) have been reported among nonadherent patients.\
                                                                                                                                                                                                                                                                                                                           Patients nonadherent to long-term home nebuliser were found to continue smoking ([@b81-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Running out of medications was one of the reasons for nonadherence ([@b22-copd-2-253])\
                                                                                                                                                                                                                                                                                                                           Patients with greater depression scores were nonadherent to regular inhaled respiratory medications ([@b9-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Patients who had good relationship family and friends had a desire to live longer and gave up smoking ([@b36-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Nonadherent subjects had greater disruption in their home and family life ([@b81-copd-2-253]).

  Value of illness threat reduction                                                                                                                                                                                                                                                                                        

  Susceptibility or resusceptibility (incl. belief in diagnosis)Vulnerability to illness in generalExtent of possible bodily harm (at motivating, but not inhibiting, levels)Extent of possible interference with social roles (at motivating, but not inhibiting, levels)Presence of (or past experience with) symptoms   Severity of respiratory symptoms and lung function predicted adherence to nebulizer ([@b81-copd-2-253]), inhaled bronchodilator ([@b13-copd-2-253]), and Long-term Oxygen Therapy ([@b69-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Absence of respiratory symptoms ([@b85-copd-2-253]) and feeling well ([@b52-copd-2-253]) were associated with nonadherence.\
                                                                                                                                                                                                                                                                                                                           Patients made variations in their recommended management based on how they felt.([@b34-copd-2-253])\
                                                                                                                                                                                                                                                                                                                           Worsening of respiratory symptoms might have contributed to improvement in adherence to supplemental oxygen with time in individuals with hypoxemic COPD ([@b24-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Greater impairment in quality of life was found to be associated with poor adherence to treatment ([@b8-copd-2-253]; [@b18-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Poor prognosis of COPD was found to be a major demotivating factor to quit smoking ([@b36-copd-2-253]).

  Probability that compliant behavior will reduce the threat                                                                                                                                                                                                                                                               

  Proposed regimen's safetyProposed regimen's efficacy to prevent, delay or cure (including 'faith in doctors and medical care' and 'chance of recovery')                                                                                                                                                                  Greater understanding about COPD and its management, and greater confidence that the current management would keep illness under control were found to be associated with better adherence ([@b34-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Perceived lack of benefit derived from treatment might have influenced discontinuation of theophylline, despite renewal of prescription ([@b79-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Nonadherent subjects had less confidence in long-term home nebulizer treatment ([@b81-copd-2-253]).

  Demographic factors\                                                                                                                                                                                                                                                                                                     Cognitive impairment and memory loss, characteristic features of old age, were associated with poor adherence to medication regimens in ambulatory patients ([@b48-copd-2-253]).\
  (Very young or old)                                                                                                                                                                                                                                                                                                      Elderly patients' competence with metered-dose inhaler technique was associated with their cognition ([@b1-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Getting confused about medications was an independent predictor of nonadherence ([@b34-copd-2-253]).

  Structural factors\                                                                                                                                                                                                                                                                                                      Increasing cost of cigarettes and affordability of smoking cessation therapies were facilitators for smoking cessation ([@b36-copd-2-253]).\
  (Cost, duration, complexity, side effects, accessibility of regimen, need for new patterns of behavior)                                                                                                                                                                                                                  Prescription of multiple inhalation devices that need to be handled differently was found to confuse patients resulting in incompetent inhalation techniques ([@b84-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Better adherence with oral theophylline than inhaled anti-inflammatory medications could have been due to simplicity of regimen and/or less concerns about side effects ([@b54-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Side effects or concerns about side effects from medications ([@b22-copd-2-253]; [@b24-copd-2-253]; Dowson et al 2004; [@b70-copd-2-253]; [@b69-copd-2-253]; [@b36-copd-2-253]), and finding medications to be physically challenging, inconvenient or unpleasant ([@b70-copd-2-253]; [@b69-copd-2-253];[@b2-copd-2-253]; [@b24-copd-2-253]; [@b34-copd-2-253]) have been found to be associated with nonadherence.\
                                                                                                                                                                                                                                                                                                                           Interruptions or changes in routines ([@b22-copd-2-253]), lack of time ([@b2-copd-2-253]; [@b85-copd-2-253]), and forgetting to take the dose ([@b2-copd-2-253]; [@b22-copd-2-253]; [@b70-copd-2-253]; [@b85-copd-2-253]) have been reported as reasons for nonadherence.

  Attitudes\                                                                                                                                                                                                                                                                                                               Adherent patients were more satisfied with their treatment and doctors than their nonadherent counterparts.([@b34-copd-2-253])\
  (Satisfaction with visit, physician, other staff, clinic procedures and facilities)                                                                                                                                                                                                                                      Patient satisfaction with the treatment had significant correlation with medication adherence ([@b64-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           The referring doctor is known to play a key role in the uptake of pulmonary rehabilitation programmes ([@b4-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Metered-dose inhaler techniques were found to be better in patients who were initiated on them in the hospital than by their general practitioner ([@b1-copd-2-253]).

  Interaction\                                                                                                                                                                                                                                                                                                             Follow-up education ([@b70-copd-2-253]; [@b8-copd-2-253]; [@b69-copd-2-253]; [@b30-copd-2-253]) and feedback on usage ([@b74-copd-2-253]) have been shown to improve medication adherence.\
  (length, depth, continuity, mutuality of expectation, quality and type of doctor-patient relationship, physician agreement with patient, feedback to patient)                                                                                                                                                            Smokers complained about their health professionals lacking empathy and being inconsiderate about their difficulties; however unfriendly approaches had prompted smoking cessation in some patients ([@b36-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Improvement in adherence with inhaled medications over time has been attributed to the improvement in patients' knowledge and understanding about their medications ([@b13-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Instruction has been shown to improve inhalation technique ([@b46-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Medication dumping was less in patients who were aware that their adherence was being monitored ([@b75-copd-2-253]).

  Enabling factors\                                                                                                                                                                                                                                                                                                        Lack of effect or perceived benefit from treatment ([@b69-copd-2-253];[@b2-copd-2-253]; [@b24-copd-2-253]) have been shown to result in nonadherence.\
  (Prior experience with action, illness or regimen; source of advice and referral (incl. social pressure)                                                                                                                                                                                                                 Experiences from explicit or subconscious experimentation with Long Term Oxygen Therapy has been found to influence future decisions to use that therapy ([@b24-copd-2-253]).\
                                                                                                                                                                                                                                                                                                                           Compromise on social status or role in the family due to the use of home oxygen was found to result in nonadherence ([@b24-copd-2-253]).
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